Corbus Pharmaceuticals Holdings, Inc. - 8-K Summary
Business Context and Reporting Period
This Form 8-K was filed by Corbus Pharmaceuticals Holdings, Inc. on September 25, 2020, reporting an event that occurred on September 22, 2020. The Company is a biopharmaceutical entity incorporated in Delaware and trades on The Nasdaq Global Market under the symbol CRBP.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial performance data.
Material Changes
The material change reported is the departure of a director from the Board of Directors.
- Event: George Golumbeski submitted his resignation from the Board of Directors.
- Effective Date: September 22, 2020.
- Reason: The resignation was not the result of any disagreement with the Company regarding operations, policies, or practices.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary on future performance, risks, contingencies, or unusual items beyond the director resignation.
Key Facts for Investor Verification
- George Golumbeski is no longer a member of the Board of Directors as of September 22, 2020.
- The departure was voluntary and not related to any dispute with the Company.
- Investors should verify if a replacement director has been appointed in subsequent filings.